Join the live Q&A on PrEP, the latest in HIV prevention. Text your questions to 713-526-1111 and tune in Monday to learn ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...
The Trump administration's global aid freeze is threatening the lives of HIV-positive orphans at Nyumbani Children’s Home in Nairobi.
On Thursday night Judge Amir H. Ali of the U.S. District Court for the District of Columbia denied a motion to hold the Trump ...
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...
This May will see the Tackle HIV Challenging Stigma Garden in full bloom at the RHS Chelsea Flower Show, with visitors set to view how Thomas and Malde have used the magic of horticulture to tell the ...
Since 2005, the institute has treated 16,303 HIV patients, with 4,180 currently receiving antiretroviral therapy (ART) at the ...
The initial accounting by DOGE of its estimated savings was overstated by billions of dollars, a review by CBS News found.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results